Anamorelin Hydrochloride
็้ ธ้ฟๆ่ซๆ
Report date: 2026/03/31 20:00:21
NME
Base Information
Drug NameAnamorelin Hydrochloride
Drug Alias Name +[13]ย
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[11]ย
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2021/01/22
Country/Territory +[26]ย
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A
Develop Information
Active CompaniesShanghai Fosun Pharmaceutical (Group) Co LtdTufts UniversityThe University Of Texas MD Anderson Cancer Center +[6]ย
Inactive CompaniesLahey Clinic IncHelsinn Therapeutics (U.S.) Inc
Active Indications +[10]ย
Inactive Indications